Jang-Woo Park

Title: Jang-Woo Park: Innovator in Aspergillus Research

Introduction

Jang-Woo Park is a notable inventor based in Gyeonggi, South Korea. He has made significant contributions to the field of microbiology, particularly through his innovative work with the Aspergillus genus. His research focuses on enhancing the productivity of valuable compounds while minimizing byproducts.

Latest Patents

Jang-Woo Park holds a patent for a novel mutant of Aspergillus terreus that exhibits resistance to both cerulenin and L-methionine analogue. This invention relates to a process for preparing mevinolinic acid, which involves the aerobic culture of the mutant strain and the recovery of mevinolinic acid. The mutant strain demonstrates remarkably high productivity of mevinolinic acid while reducing the production of byproducts, such as mevinolinic acid analogues, compared to the wild type Aspergillus terreus isolated from the soil environment in Korea. Additionally, this mutant successfully produces mevinolinic acid using monosaccharides like glucose and galactose, unlike the mother strain.

Career Highlights

Jang-Woo Park is associated with Chong Kun Dang Corporation, where he continues to advance his research and development efforts. His work has positioned him as a key figure in the field of biotechnology, particularly in the production of pharmaceutical compounds.

Collaborations

Some of his notable coworkers include Chung-Il Hong and Jung-Woo Kim, who have collaborated with him on various research projects.

Conclusion

Jang-Woo Park's innovative work with Aspergillus terreus has the potential to significantly impact the production of mevinolinic acid, showcasing his contributions to biotechnology and microbiology. His research not only enhances productivity but also paves the way for more efficient processes in pharmaceutical manufacturing.